Abstract:The porcine reproductive and respiratory syndrome viruses (PRRSV) led to a global panzootic and huge economical losses to the pork industry. PRRSV targets the scavenger receptor CD163 for productive infection. However, currently no effective treatment is available to control the spread of this disease. Using bimolecular fluorescence complementation (BiFC) assays, we screened a set of small molecules potentially targeting the scavenger receptor cysteine-rich domain 5 (SRCR5) of CD163. We found that the assay examining protein-protein interactions (PPI) between PRRSV glycoprotein 4 (GP4) and the CD163-SRCR5 domain mainly identifies compounds that potently inhibit PRRSV infection, while examining the PPI between PRRSV-GP2a and the SRCR5 domain maximized the identification of positive compounds, including additional ones with various antiviral capabilities. These positive compounds significantly inhibited both types 1 and 2 PRRSV infection of porcine alveolar macrophages. We confirmed that the highly active compounds physically bind to the CD163-SRCR5 protein, with dissociation constant (KD) values ranging from 28 to 39 μM. Structure-activity-relationship (SAR) analysis revealed that although both the 3-(morpholinosulfonyl)anilino and benzenesulfonamide moieties in these compounds are critical for the potency to inhibit PRRSV infection, the morpholinosulfonyl group can be replaced by chlorine substituents without significant loss of antiviral potency. Our study established a system for throughput screening of natural or synthetic compounds highly effective on blocking of PRRSV infection and shed light on further SAR modification of these compounds. IMPORTANCE Porcine reproductive and respiratory syndrome virus (PRRSV) causes significant economic losses to the swine industry worldwide. Current vaccines cannot provide cross protection against different strains, and there are no effective treatments available to hamper the spread of this disease. In this study, we identified a group of new small molecules that can inhibit the PRRSV interaction with its specific receptor CD163 and dramatically block the infection of both types 1 and type 2 PRRSVs to host cells. We also demonstrated the physical association of these compounds with the SRCR5 domain of CD163. In addition, molecular docking and structure-activity relationship analyses provided new insights for the CD163/PRRSV glycoprotein interaction and further improvement of these compounds against PRRSV infection.

Ursolic acid derivatives are potent inhibitors against porcine reproductive and respiratory syndrome virus

A transgenic Marc-145 cell line of piggyBac transposon-derived targeting shRNA interference against porcine reproductive and respiratory syndrome virus.

Identification and Characterization of Small Molecule Inhibitors of Porcine Reproductive and Respiratory Syndrome Virus

Molecular Characterization of Three Porcine Reproductive and Respiratory Syndrome Virus Isolates and Their Susceptibility to Antiviral Drugs

Ursonic acid from medicinal herbs inhibits PRRSV replication through activation of the innate immune response by targeting the phosphatase PTPN1

Inhibition of Porcine Reproductive and Respiratory Syndrome Virus Replication by Adenovirus-Mediated RNA Interference Both in Porcine Alveolar Macrophages and Swine.

The effect of matrine and glycyrrhizic acid on porcine reproductive and respiratory syndrome virus in Vitro and in vivo

Effective Suppression of Replication of Porcine Reproductive and Respiratory Syndrome Virus by Adenovirus-Mediated Small Interfering RNAs Targeting ORF1b, 5 and 7 Genes

Synthetic Toll-like receptor 7 ligand inhibits porcine reproductive and respiratory syndrome virus infection in primary porcine alveolar macrophages

Cryptoporus Volvatus Extract Inhibits Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in Vitro and in Vivo

Platycodin D Suppresses Type 2 Porcine Reproductive And Respiratory Syndrome Virus In Primary And Established Cell Lines

Antiviral activity of recombinant porcine surfactant protein A against porcine reproductive and respiratory syndrome virus in vitro

Identification of New Compounds against PRRSV Infection by Directly Targeting CD163

Caffeic Acid Phenethyl Ester: an Effective Antiviral Agent Against Porcine Reproductive and Respiratory Syndrome Virus

Inhibition of Porcine Reproductive and Respiratory Syndrome Virus Replication by Short Hairpin RNA in MARC-145 Cells.

Inhibition of Porcine Reproductive and Respiratory Syndrome Virus Replication by Flavaspidic Acid Ab

A synthetic toll-like receptor 7 agonist inhibits porcine reproductive and respiratory syndrome virus replication in piglets

Identification of Two Antiviral Inhibitors Targeting 3C-Like Serine/3c-Like Protease of Porcine Reproductive and Respiratory Syndrome Virus and Porcine Epidemic Diarrhea Virus.

Betulonic Acid Inhibits Type-2 Porcine Reproductive and Respiratory Syndrome Virus Replication by Downregulating Cellular ATP Production

In vitro screening for compounds derived from traditional chinese medicines with antiviral activities against porcine reproductive and respiratory syndrome virus.

Inhibition of HSP90 attenuates porcine reproductive and respiratory syndrome virus production in vitro